STOCK TITAN

DuPont to Complete Sale of ~80% Ownership in Delrin® Business to TJC

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
DuPont will complete the sale of an 80.1% ownership interest in the Delrin acetal homopolymer business to TJC LP for $1.8 billion. DuPont will receive pre-tax cash proceeds of approximately $1.28 billion and retain a 19.9% non-controlling common equity interest in the Delrin business.
Positive
  • None.
Negative
  • None.

WILMINGTON, Del., Nov. 1, 2023 /PRNewswire/ -- DuPont (NYSE: DD) announced that today it will complete its previously announced sale of an 80.1% ownership interest in the Delrin® acetal homopolymer (H-POM) business to an affiliate of TJC LP (TJC) in a transaction valuing the business at $1.8 billion.

At close, DuPont will receive pre-tax cash proceeds of approximately $1.28 billion which includes certain customary transaction adjustments, a note receivable of $350 million, and will retain a 19.9% non-controlling common equity interest in the Delrin business.

DuPont will hold its third quarter earnings conference call today, November 1st at 8:00 a.m. ET.

About TJC
TJC (formerly known as The Jordan Company, L.P.), founded in 1982, is a middle-market private equity firm that has raised funds with original capital commitments in excess of $23 billion and a 41-year track record of investing in and contributing to the growth of many businesses across a wide range of industries including Diversified Industrials; Technology, Telecom & Power; Logistics & Supply Chain and Consumer & Healthcare. The senior investment team has been investing together for over 20 years and is supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies. TJC has offices in New York, Miami, Chicago and Stamford. For more information, visit www.tjclp.com.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com

Cautionary Statement Regarding Forward Looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) risks and uncertainties related to the settlement agreement concerning PFAS liabilities reached June 2023 with plaintiff water utilities by Chemours, Corteva, EIDP and DuPont, including timing of court approval and the level of opt-outs from the settlement; (ii) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and between DuPont, Corteva and Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; changes in laws and regulations applicable to PFAS chemicals; (iii) ability to achieve anticipated tax treatments in connection with mergers, acquisitions, divestitures and other portfolio changes actions and impact of changes in relevant tax and other laws; (iv) indemnification of certain legacy liabilities; (v) failure to timely close on anticipated terms (or at all), realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with mergers, acquisitions, divestitures and other portfolio management, productivity and infrastructure actions; (vi) risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs from, among other events, pandemics and responsive actions; timing and recovery from demand declines in consumer-facing markets, including in China; adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions; and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or weather related events, that impact the operations of the Company, its customers and/or suppliers; (vii) ability to offset increases in cost of inputs, including raw materials, energy and logistics; (viii) risks associated with demand and market conditions in the semiconductor industry and associated end markets, including from continuing or expanding trade disputes or restrictions, including on exports to China of U.S.-regulated products and technology; (ix) risks, including ability to achieve, and costs associated with DuPont's sustainability strategy including the actual conduct of the company's activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; and (x) other risks to DuPont's business, operations; each as further discussed in DuPont's most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-to-complete-sale-of-80-ownership-in-delrin-business-to-tjc-301973378.html

SOURCE DuPont

FAQ

What is the name of the company mentioned in the press release?

The company mentioned in the press release is DuPont.

What is being sold by DuPont in this transaction?

DuPont is selling an 80.1% ownership interest in the Delrin acetal homopolymer business.

Who is acquiring the ownership interest in the Delrin business?

The ownership interest in the Delrin business is being acquired by an affiliate of TJC LP (TJC).

What is the valuation of the Delrin business in this transaction?

The Delrin business is valued at $1.8 billion in this transaction.

How much cash proceeds will DuPont receive from the sale?

DuPont will receive approximately $1.28 billion in pre-tax cash proceeds from the sale.

What will DuPont retain after the sale?

DuPont will retain a 19.9% non-controlling common equity interest in the Delrin business.

When is DuPont's third quarter earnings conference call?

DuPont's third quarter earnings conference call will be held today, November 1st at 8:00 a.m. ET.

DuPont de Nemours, Inc.

NYSE:DD

DD Rankings

DD Latest News

DD Stock Data

32.03B
417.37M
0.12%
72.2%
0.86%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States of America
WILMINGTON